SCHEMBL5259674

SCHEMBL5259674

O=C(O)/C(=C\c1c[nH]c2ncccc12)c1ccc(-c2ccccc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CAMKK2 Q96RR4 4/20 0.53
KMT2A Q03164 2/20 0.51
CHEK1 O14757 2/20 0.47
POLB P06746 2/20 0.44
MEN1 O00255 1/20 0.44
SGK1 O00141 3/20 0.44
AXL P30530 2/20 0.44
AAK1 Q2M2I8 1/20 0.42
CDC7 O00311 1/20 0.41
MAP2K1 Q02750 1/20 0.41
NEK2 P51955 1/20 0.41
PLK1 P53350 1/20 0.41
CCNT1 O60563 1/20 0.41
CDK9 P50750 1/20 0.41
HASPIN Q8TF76 1/20 0.41
MET P08581 1/20 0.40
ADORA2A P29274 1/20 0.40
CCNE1 P24864 1/20 0.40
CDK2 P24941 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5259675 1.00 CAMKK2 (0.53) CAMKK2KMT2ACHEK1POLBMEN1
SCHEMBL5258775 0.92 KMT2A (0.56) CAMKK2KMT2ACHEK1AXLCDC7
SCHEMBL5263254 0.92 KMT2A (0.56) CAMKK2KMT2ACHEK1AXLCDC7
SCHEMBL5258776 0.92 KMT2A (0.56) CAMKK2KMT2ACHEK1AXLCDC7
SCHEMBL5263637 0.91 CAMKK2 (0.53) CAMKK2KMT2ACHEK1SGK1AXL
SCHEMBL5263639 0.91 CAMKK2 (0.53) CAMKK2KMT2ACHEK1SGK1AXL
SCHEMBL5260884 0.89 KMT2A (0.52) CAMKK2KMT2ACHEK1POLBMEN1
SCHEMBL5260881 0.89 KMT2A (0.52) CAMKK2KMT2ACHEK1POLBMEN1
SCHEMBL5262886 0.88 KMT2A (0.51) CAMKK2KMT2ACHEK1MEN1AXL
SCHEMBL5259149 0.88 KMT2A (0.51) CAMKK2KMT2ACHEK1MEN1AXL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1309590-B1 AZAINDOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND THEIR USE AS ANTITUMOR AGENTS PFIZER ITALIA SRL (IT) 2007-09-19 EP claimed
US-20030004350-A1 AZAINDOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND THEIR USE AS ANTITUMOR AGENTS PHARMACIA & UPJOHN (IT) 2003-01-02 US claimed
US-6335342-B1 1H-PYRROLO(2,3-B)PYRIDINE DERIVATIVES; ANTICARCINOGENIC, ANTIMETASTASIS, ANTITUMOR AND ANTIPROLIFERATIVE AGENTS PHARMACIA & UPJOHN S.P.A. (IT) 2002-01-01 US claimed
EP-1309590-B1 AZAINDOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND THEIR USE AS ANTITUMOR AGENTS PFIZER ITALIA SRL (IT) 2007-09-19 EP disclosed
US-20030004350-A1 AZAINDOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND THEIR USE AS ANTITUMOR AGENTS PHARMACIA & UPJOHN (IT) 2003-01-02 US disclosed
US-6486322-B1 Azaindole derivatives, process for their preparation, and their use as antitumor agents PHARMACIA ITALIA S.P.A. (IT) 2002-11-26 US disclosed
US-6335342-B1 1H-PYRROLO(2,3-B)PYRIDINE DERIVATIVES; ANTICARCINOGENIC, ANTIMETASTASIS, ANTITUMOR AND ANTIPROLIFERATIVE AGENTS PHARMACIA & UPJOHN S.P.A. (IT) 2002-01-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030004350-A1 AZAINDOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND THEIR USE AS ANTITUMOR AGENTS FFAR4, AZI2, CNKSR1 CAMKK2 2052/4885KMT2A 1011/4885CHEK1 337/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.